Adorini L - Search Results

1

Adorini L, Trauner M. Adorini L, et al. J Hepatol. 2023 Nov;79(5):1317-1331. doi: 10.1016/j.jhep.2023.07.034. Epub 2023 Aug 9. J Hepatol. 2023. PMID: 37562746 Free article. Review.

2

An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations.

Carr RM, Li Y, Chau L, Friedman ES, Lee JJ, Adorini L, Erickson M, Zaru L, Shringarpure R, MacConell L, Bittinger K, Li H, Wu GD. Carr RM, et al. Among authors: adorini l. Hepatology. 2023 Dec 1;78(6):1843-1857. doi: 10.1097/HEP.0000000000000474. Epub 2023 May 25. Hepatology. 2023. PMID: 37222264

3

FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH.

Di Pasqua LG, Cagna M, Palladini G, Croce AC, Cadamuro M, Fabris L, Perlini S, Adorini L, Ferrigno A, Vairetti M. Di Pasqua LG, et al. Among authors: adorini l. Liver Int. 2024 Jan;44(1):214-227. doi: 10.1111/liv.15767. Epub 2023 Oct 30. Liver Int. 2024. PMID: 37904642

4

Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2.

Smyth JS, Truong JK, Rao A, Lin R, Foulke-Abel J, Adorini L, Donowitz M, Dawson PA, Keely SJ. Smyth JS, et al. Among authors: adorini l. Am J Physiol Gastrointest Liver Physiol. 2023 Nov 1;325(5):G446-G452. doi: 10.1152/ajpgi.00099.2023. Epub 2023 Sep 12. Am J Physiol Gastrointest Liver Physiol. 2023. PMID: 37697930 Free article.

5

Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis.

Adorini L, Rigbolt K, Feigh M, Roth J, Erickson M. Adorini L, et al. PLoS One. 2024 Apr 25;19(4):e0300809. doi: 10.1371/journal.pone.0300809. eCollection 2024. PLoS One. 2024. PMID: 38662778 Free PMC article.

6

The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice.

Wang XX, Xie C, Libby AE, Ranjit S, Levi J, Myakala K, Bhasin K, Jones BA, Orlicky DJ, Takahashi S, Dvornikov A, Kleiner DE, Hewitt SM, Adorini L, Kopp JB, Krausz KW, Rosenberg A, McManaman JL, Robertson CE, Ir D, Frank DN, Luo Y, Gonzalez FJ, Gratton E, Levi M. Wang XX, et al. Among authors: adorini l. J Biol Chem. 2022 Nov;298(11):102530. doi: 10.1016/j.jbc.2022.102530. Epub 2022 Oct 7. J Biol Chem. 2022. PMID: 36209823 Free PMC article.

7

Farnesoid X receptor activation by the novel agonist TC-100 (3α, 7α, 11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid) preserves the intestinal barrier integrity and promotes intestinal microbial reshaping in a mouse model of obstructed bile acid flow.

Marzano M, Fosso B, Colliva C, Notario E, Passeri D, Intranuovo M, Gioiello A, Adorini L, Pesole G, Pellicciari R, Moschetta A, Gadaleta RM. Marzano M, et al. Among authors: adorini l. Biomed Pharmacother. 2022 Sep;153:113380. doi: 10.1016/j.biopha.2022.113380. Epub 2022 Jul 19. Biomed Pharmacother. 2022. PMID: 36076475 Free article.

8

Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice.

Morel C, Chowdhary V, Thevkar Nagesh P, Ribeiro M, Hawryluk D, Catalano D, Adorini L, Szabo G. Morel C, et al. Among authors: adorini l. Liver Int. 2023 Jan;43(1):100-114. doi: 10.1111/liv.15374. Epub 2022 Aug 8. Liver Int. 2023. PMID: 35869657 Free PMC article.

9

Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism.

Gillard J, Picalausa C, Ullmer C, Adorini L, Staels B, Tailleux A, Leclercq IA. Gillard J, et al. Among authors: adorini l. Nutrients. 2022 Jun 29;14(13):2707. doi: 10.3390/nu14132707. Nutrients. 2022. PMID: 35807885 Free PMC article.

10

Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats.

Palladini G, Cagna M, Di Pasqua LG, Adorini L, Croce AC, Perlini S, Ferrigno A, Berardo C, Vairetti M. Palladini G, et al. Among authors: adorini l. Pharmaceuticals (Basel). 2022 Apr 24;15(5):524. doi: 10.3390/ph15050524. Pharmaceuticals (Basel). 2022. PMID: 35631351 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

332 results

Search Page